Exubera® Vs Needles
8th September 2005 -- A US government advisorycommittee is scrutinizing an inhaled form of insulin. The new drug is designed to help millions of people with diabetes who currently rely on injections to control their blood sugar levels. The chief concern about the drug involves its long-term effects on the lungs. The committee will also assess whether it is safe and effective for people who smoke or have lung disease, according to documents released by the US Food and Drug Administration. The inhaled insulin, being developed by Pfizer, Sanofi-Aventis and Nektar Therapeutics, is called Exubera®, could help diabetics who are reluctant to take injections. However, during drug trials, some patients who tested the inhaled insulin complained of coughing and a small decrease in breathing capacity. -- The Daily MailCoughing and a small decrease in breathing capacity? Might even give cigarettes a run for it's money. Sorry, smoker's joke.
posted by A.D. at 7:53 PM
1 Comments:
On Sep 9th, The FDA recommended the approval of Exubera®, the first inhaled insulin drug. But some concerns were raised and cautionly advised:
"The panel endorsed Exubera® for adults with juvenile- or adult-onset diabetes. Exubera is short-acting insulin that can be taken before meals. It would not replace long-acting insulin shots taken before bedtime. The drug's label will warn that smokers should not use Exubera because smoking increases the effect of insulin and could cause dangerous drops in blood-sugar levels, Pfizer said."
Post a Comment
<< Home